ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction.
Miyakawa K, Matsunaga S, Kanou K, Matsuzawa A, Morishita R, Kudoh A, Shindo K, Yokoyama M, Sato H, Kimura H, Tamura T, Yamamoto N, Ichijo H, Takaori-Kondo A, Ryo A.
Miyakawa K, et al. Among authors: shindo k.
Nat Commun. 2015 Apr 22;6:6945. doi: 10.1038/ncomms7945.
Nat Commun. 2015.
PMID: 25901786
Free PMC article.